Copyright
©2012 Baishideng Publishing Group Co.
World J Cardiol. Aug 26, 2012; 4(8): 256-259
Published online Aug 26, 2012. doi: 10.4330/wjc.v4.i8.256
Published online Aug 26, 2012. doi: 10.4330/wjc.v4.i8.256
Table 1 Clinical data before and after eicosapentaenoic acid administration (n = 19)
Variables | Pre-administration | After-administration | P value |
Systemic hypertension | 17 (89%) | 17 (89%) | NS |
Dyslipidemia | 14 (74%) | 14 (74%) | NS |
Body mass index (kg/m2) | 23.9 ± 2.3 | 23.9 ± 2.5 | NS |
Systolic BP (mmHg) | 131 ± 16 | 130 ± 13 | NS |
Diastolic BP (mmHg) | 83 ± 9 | 80 ± 7 | NS |
Triglyceride (mg/dL) | 107 ± 52 | 99 ± 24 | NS |
LDL cholesterol (mg/dL) | 114 ± 29 | 108 ± 28 | NS |
EPA (%) | 3.0 ± 1.1 | 8.5 ± 2.9 | < 0.001 |
- Citation: Haiden M, Miyasaka Y, Kimura Y, Tsujimoto S, Maeba H, Suwa Y, Iwasaka T, Shiojima I. Effect of eicosapentaenoic acid on regional arterial stiffness: Assessment by tissue Doppler imaging. World J Cardiol 2012; 4(8): 256-259
- URL: https://www.wjgnet.com/1949-8462/full/v4/i8/256.htm
- DOI: https://dx.doi.org/10.4330/wjc.v4.i8.256